Here you can read all news about stem cells.
Here you can read all news about stem cells.
5 May 2020
How Does Coronavirus Affect the Body
Pulmonary Consequences of COVID-19
Cardiac Implications of Coronavirus
Neurological Disorders Caused by COVID-19
Thromboembolic Complications in COVID-19 Patients
Health Rehabilitation Programme After Coronavirus
What Stem Cells Can Do For Coronavirus Complications
Additional Therapies for Rehabilitation
A coronavirus pandemic has serious implications for the health of the human population, and these consequences have not yet been fully assessed.
An acute viral disease, such as a coronavirus, can worsen the health of patients with chronic conditions or trigger various pathologies, primarily pulmonary and cardiovascular.
Currently, there are no other measures to prevent the disease, except for self-isolation, and there are no specific medications for its treatment, though many are under investigation. In these circumstances, doctors have to concentrate on overcoming the possible consequences of viral exposure on the patient's body after the acute stage of the disease has been successfully resolved.
Patients with the following illnesses may require rehabilitation after severe pneumonia or SARS (severe acute respiratory syndrome):
One of the methods of rehabilitation after coronavirus is treatment with mesenchymal stem cells (MSCs), which was effectively used to treat severe COVID-19 associated pneumonia . Therapy based on cell products, together with additional therapies, can give significant results during recovery.
The COVID-19 virus is known to use the angiotensin-converting enzyme 2 (ACE2) receptor to enter cells. Therefore, the lungs, heart, brain, kidneys, intestines and testicles, which are all known to express ACE2 receptors, are potential targets for the novel coronavirus .
Initially, the virus infects the cells of the respiratory system, where it causes inflammation and cell death. Subsequently, the virus spreads and damages other vital organs and tissues, creating a complex range of pathophysiological changes and symptoms, including respiratory distress, cardiovascular complications, renal failure, etc .
Picture 1. The effects of viral exposure on the lungs and cardiovascular system .
Although the possibility is quite low, there is also the chance of direct kidney damage (which is associated with cytokine overproduction) in a new coronavirus disease .
According to recent data, the SARS-CoV-2 virus can penetrate red blood cells and attack haemoglobin, which deprives the red blood cells of the ability to transport oxygen. That is, it leads to disruption in the transport of oxygen through the bloodstream, followed by the development of symptoms of acute respiratory distress (ARDS) and multi-organ oxygen deficiency. The accumulation of products of this attack, in the lung tissue, is associated with the so-called ground-glass-like lung images. This symptom is observed on computer tomography (CT) scan even in asymptomatic patients with coronavirus .
It is assumed that the main complication, after COVID-19, is specifically to the lungs. The combination of an inflammatory process in the lung (pneumonia) and the use of artificial ventilation can trigger the development of pulmonary fibrosis .
Fibrosis is a pathological growth of connective tissue, due to an immune response to local inflammation. When healthy lung tissue is replaced by connective tissue (scarring), the functioning of the lung deteriorates, and symptoms such as shortness of breath, coughing, weakness and low exercise tolerance may develop. This condition can develop as a long-term consequence of a viral infection, months after recovery, and years before it is diagnosed.
There is evidence that the virus causes damage to the cardiovascular system. According to the American College of Cardiology, the presence of coronavirus in a patient's body can precipitate cardiac complications. In particular, 16% of hospitalised patients developed arrhythmia, while other reports indicate cases of acute-onset heart failure, heart attack and cardiac arrest after the viral infection .
A statistical report on a group of patients hospitalised with COVID-19 found that more than 7% developed acute cardiac injury. In contrast, patients in the intensive care unit (ICU) had a higher risk (>20%) of having cardiac injury compared to non-ICU patients .
There was evidence of myocardial injury, and 12.5% of COVID-19 patients had cardiac abnormalities similar to myocarditis .
Also, there are warnings about heart-related damage due to the use of medications such as hydroxychloroquine alone or in combination with azithromycin .
Coronaviruses, as a group of related viruses, have already been suspected of harming the central nervous system .
Picture 2. Neurological insights of COVID-19 .
As for the new virus, COVID-19, its entry into the bloodstream allows it to penetrate the cerebral circulation. An additional pathway for the virus to enter and affect the brain is via the cribriform plate close to the olfactory bulb . Patients affected by the virus have reported neurological symptoms such as headache, dizziness, myalgia, anosmia, ataxia, seizures and other more severe signs of a lesion , .
There is evidence of the development of encephalopathy due to viral brain damage. Scientists suppose that the long-term effects of the neuroinvasive nature of the virus may lead to an increased risk of neurodegenerative diseases. Also, patients with COVID-19 that have pre-existing neurological disorders such as Parkinson’s disease or multiple sclerosis are likely to experience a worsening of their condition .
According to significant data and studies, viral damage from COVID-19 is accompanied not only by an inflammatory reaction but also microvascular thrombosis in predisposed individuals. The medical histories of many patients infected with coronavirus showed they had disseminated intravascular coagulation (DIC). DIC is a condition where clots form due to increased blood coagulation, blocking vessels. The so-called endothelial thrombo-inflammatory syndrome can affect the microvascular bed of the brain, as well as other vital organs , , .
Blockage of the pulmonary vessels may be associated with respiratory and/or heart failure. Also, the large number of reports of strokes in COVID-19-positive individuals can be explained by the high thromboembolic risk of a new coronavirus , .
In the process of patient recovery, specific measures may be required to restore their affected health. First, a damage assessment and a complete check-up of the patient's overall health status is performed. Diagnostics include (according to indication):
Based on the results and depending on the patient’s medical needs, an individual rehabilitation programme is developed with a focus on the lungs, heart, kidney failure and/or neurological disorders.
The inclusion of specific procedures in the rehabilitation programme depends on the diagnosis, the severity of the injuries, the general health condition of the patient and the prognosis. In most cases, we use at least the following therapies, as they have already proven effective in recovery from severe viral pneumonia and its consequences:
We are going to describe these therapies in the text below.
Contact our medical advisor to receive a personal health recovery programme after COVID-19 >>>
Post-viral complications are associated with an excessive immune response (due to a cytokine storm), as well as viral damage to tissues . Related to this, mesenchymal stem cells (MSCs) are an excellent therapeutic choice due to their regenerative and immunomodulatory properties. They protect the lungs from acute respiratory distress syndrome (ARDS) by secreting antibacterial peptides and anti-inflammatory cytokines .
After intravenous transplantation of MSCs, a significant population of cells accumulate in the lungs, which can protect alveolar epithelial cells, reclaim the pulmonary microenvironment, prevent pulmonary fibrosis and cure lung dysfunction. This result is in addition to their immunomodulatory effect .
In general, introduced stem cells enhance survival and renewal of healthy local cells and help to restore lost functions in tissues and organs .
Picture 3. Intravenous therapies take time but are safe and painless.
1. Intracellular metabolism recovery (IMR) therapy is an individually selected combination of useful substances (trace elements, amino acids, vitamins and others) administered intravenously. Once in the patient's bloodstream, this therapeutic compound:
2. Interval hypoxic-hyperoxic therapy (IHHT) destroys worn out, old mitochondria and accelerates the formation of healthier, physiologically younger mitochondria in the cells. This effect is due to the strengthening of ventilation in the alveoli, simplification of sputum evacuation, activation of the body's antioxidant system, improvement of blood flow in tissues and organs. Also, hypoxicotherapy:
3. Plasmapheresis (plasma exchange, Stanford protocol). This procedure allows the quick removal of biological products from the bloodstream and tissues, for example, the breakdown of bacteria, viruses, virus-damaged cells and the result of the immune response to the viral exposure. Plasmapheresis also improves respiration and cell nutrition, increases organ blood flow, activates the regeneration processes, which helps to restore the normal functioning of the body after disease and enhances the patient's well-being .
4. Other additional therapies may be prescribed, as specified, and include xenon gas, oxygen therapy, intravenous laser/ultraviolet blood therapy, etc.
Contact our medical advisor to receive a personalised rehabilitation programme after COVID-19 >>>
— Published on May 5, 2020
by Swiss Medica team >>
Our primary task is to make your own cells treat your own body. We use advanced technology to activate mesenchymal stem cells derived from adipose tissue, bone marrow, etc. Donated cells can also be used. Introduced to the patient’s body, these cells help to regenerate damaged tissue. Symptoms become less obvious and/or disappear.
*Patient feedback, articles and testimonials provided on this site are for informational purposes only and should not be considered as a guaranteed result for every case of illness. The treatment result depends on the disease, patient’s condition, number of treatment procedures, etc.
All form fields are required.